LUPIN PHARMACEUTICALS, INC.
NAPLES, FLORIDA

Lupin Pharmaceuticals, Inc., the U.S. wholly owned subsidiary of Indian pharmaceutical giant Lupin Limited, serves as a key player in delivering high-quality branded and generic medications that are trusted by healthcare professionals and patients worldwide. Headquartered in Baltimore, MD, with corporate roots deeply connected to its parent company in Mumbai, India, it embodies a comprehensive approach to research-driven product development. Through an advanced R&D presence in Pune, Lupin Limited pioneers crucial medical categories such as Anti-TB, anti-infectives (Cephalosporins), cardiovascular drugs (including ACE inhibitors and cholesterol-lowering agents), as well as therapies for diabetes, inflammation, and respiratory conditions. Lupin Pharmaceuticals, Inc. leverages its vertical integration strategy encompassing discovery research, process chemistry, active pharmaceutical ingredient production, formulation development, and regulatory processes — a testament to its innovative transnational ambitions set forth by its leadership under CEO Vinita Gupta. The firm is on a strategic path to introducing a diverse range of generics alongside branded offerings in key markets like the U.S., reflecting an overarching mission to become a leading innovation-focused pharmaceutical company. As a registered Florida entity (FILED NUMBER: F05000007131), with a corporate presence established in Naples, Collier County, FL, Lupin Pharmaceuticals, Inc. has experienced significant milestones since its incorporation on December 8, 2005. The firm reports a consistent operational transparency as shown by events such as its latest amendment dated May 3, 2016, and maintains active compliance by filing the annual report for the year 2024 in April 2024. With an effective team led by Vinita Gupta alongside key directors like Jean-Luc Belingard, Lupin Pharmaceuticals, Inc. stands poised to expand its influence while fulfilling its vision of offering pioneering pharmaceutical solutions globally. The firm welcomes both professionals and patients visiting lupinpharmaceuticals.com for more information on their extensive product portfolio.